Skip to search formSkip to main contentSkip to account menu

Tamoxifen

Known as: Tamoxifeno, TAM, (Z)-2-[4(1,2-diphenyl-1-butenyl)-phenoxyl]-N,N-dimethylethanamine 
An antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen… 
National Institutes of Health

Related topics

Related topics

50 relations

Narrower (28)

4-hydroxy-N-desmethyltamoxifen4-hydroxyospemifene4-hydroxytoremifeneH 1285

Broader (1)

Amines
Cyclophosphamide/Fluorouracil/TamoxifenIn BloodNCIt Antineoplastic Agent TerminologyPancreatic Neoplasm

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Analysis of Factors Affecting the Use of Google Classroom to Support Lectures
The rapid development of information technology in recent years has changed the paradigm of society. One field that is getting a… 
2004
2004
High order finite difference operators with the summation by parts property based on DRP schemes
High order finite difference operators with the summation by parts property based on DRP schemes 
Highly Cited
2000
Highly Cited
2000
Fourier analysis of the femtosecond hyper-Rayleigh scattering signal from ionic fluorescent hemicyanine dyes
A series of five fluorescent and ionic dimethylamino stilbazolium homologues with increasing conjugation length (from ethenyl to… 
Highly Cited
1998
Highly Cited
1998
p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer.
PURPOSE Mutations of the p53 gene are frequently observed in primary breast cancer and accumulation of p53 protein has been used… 
Highly Cited
1994
Highly Cited
1994
Setting the record straight in the breast-cancer trials.
In 1985 the Journal published a paper from the multicenter National Surgical Adjuvant Breast and Bowel Project (NSABP) showing… 
Highly Cited
1989
Highly Cited
1989
Endometrial polyps in postmenopausal patients receiving tamoxifen.
The histologic features of an endometrial polyp include irregular, often dilated glands, thick-walled blood vessels, and a… 
Highly Cited
1986
Highly Cited
1986
Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms.
The normally quick response of platelets to alpha-thrombin is delayed under two conditions. After pretreatment of platelets with… 
Highly Cited
1978
Highly Cited
1978
Clinical analysis of tamoxifen, an anti-neoplastic agent, in plasma.
Tamoxifen, a phenylstilbene derivative, is currently being used to treat metastatic breast cancer. We describe an analytical… 
Review
1976
Review
1976
Current overview of EORTC clinical trials with tamoxifen.
Based upon concepts derived from estrogen receptor studies, a phase II exploratory trial was conducted where tamoxifen (NSC… 
1972
1972
Binding of chemical carcinogens to nuclear proteins of rat liver.
RichardA.JungmannandJohnS.SchweppeDepartmentofBiochemistryandMedicine,NorthwesternUniversityMedicalSchool,Chicago… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)